Comparison of Commercial ELISA and Rapid Tests for Diagnosis of SARS-CoV-2
A team of investigators compared the sensitivity and specificity of 4 enzyme-linked immunosorbent assays and 2 rapid tests in patients with symptomatic SARS-CoV-2 infection.
All articles by Zahra Masoud
Monitoring for Trends in COVID-19 Needed
In response to the COVID-19 pandemic, New York State implemented a series of community mitigation strategies, and monitoring approaches are needed to assess the effect of these interventions.
Predictive Markers for Severe COVID-19 Identified
Elevated lactate dehydrogenase may be a predictive marker of acute respiratory distress syndrome and morality in patients with COVID-19.
Characteristics of SARS-CoV-2 Infection, Potential Therapies for COVID-19
Progression in characterizing the symptoms and treatments for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent development of coronavirus disease 2019 (COVID-19).
Neuraminidase Inhibitor Treatment for Influenza B-Related Pneumonia
Early neuraminidase inhibitor therapy may result in better outcomes in patients hospitalized with influenza B-related pneumonia.
Pneumonia Mortality Not Improved With Empiric Anti-MRSA Therapy
Anti-methicillin-resistant Staphylococcus aureus (MRSA) therapy in addition to standard pneumonia therapy does not improve mortality.
Antibiotic and Antiviral Combination to Treat Influenza
Compared with patients prescribed only an antiviral, patients who are prescribed both an antiviral and antibiotic have a lower risk for 3-day respiratory hospitalization.
Rifampicin May Be Safer Than Isoniazid in Latent Tuberculosis Treatment
In patients without a contraindication, rifampicin may be the safest treatment option for latent tuberculosis (TB) infection.
No Association Between Influenza Severity and Pediatric Vaccination Rate
Vaccine effectiveness and severity of current and prior seasons of influenza have demonstrated no association with vaccination rate in children, according to a study published in JAMA Pediatrics. Compared with other pediatric and adolescent vaccines, the influenza vaccination rate remains low in children. Although many reasons may affect whether a child is vaccinated, the extent…
M72/AS01 Tuberculosis Vaccine Remains Efficacious After 3 Years
The M72/AS01 vaccine shows efficacy against pulmonary tuberculosis (TB) at 3 years in patients with Mycobacterium tuberculosis infection.
-
Loading...
-
Loading...
Next post in Tuberculosis
